ASX Announcements
Letter to Shareholders - Notice of Annual General Meeting
Proxy Form, Notice of Meeting - Other, Letter to Shareholders
- Oct 3, 2024
- 3 pages
Notice of Annual General Meeting/Proxy Form
Notice of Annual General Meeting, Proxy Form
- Oct 3, 2024
- 46 pages
September
The five pharma stocks exciting investors
Risky but with rewards, Australian pharmaceutical companies developing treatments for rare diseases are competing for investor attention.
- Michael Smith
August 2022
Botanix Pharmaceuticals raising for its sweating treatment
Botanix Pharmaceuticals, a listed developer of treatments for skin infections and diseases, was pitching investors for $5 million to take its Sofpironium Bromide product into sales in the United States.
- Anthony Macdonald, Sarah Thompson and Kanika Sood